Colt A. Egelston

Also affiliated with City of Hope

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial”.

PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

Nature Medicine(2024)10.1038/s41591-024-02979-8

N/A

1.8DataRank · unranked

124 citations

M. Suzette Blanchard, Lauren Adkins, Laura Luebbert, Neena A. Leggett, Stephanie N. Shishido +23 more

Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade

Blood(2023)10.1182/blood.2023020485

N/A

1.3DataRank · unranked

40 citations

Lu Chen, James Godfrey, Joo Y. Song, Colt A. Egelston, Sandrine Puverel +18 more

Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002084

N/A

1.3DataRank · unranked

32 citations

Weihua Guo, Susan E. Yost, Jin Sun Lee, D. L. ROSE, Christian Avalos +7 more

Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03470-y

N/A

0.809DataRank · unranked

22 citations

Weihua Guo, Susan E. Yost, Xuan Ge, Jin Sun Lee, Paul Frankel +12 more

Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0212

N/A

0.406DataRank · unranked

14 citations

Weihua Guo, Chongkai Wang, Colt A. Egelston, Massimo D’Apuzzo, Geereesh Shankar +3 more

CF33-hNIS-anti-PD-L1 oncolytic virus followed by trastuzumab-deruxtecan in a patient with metastatic triple negative breast cancer: a case study

Therapeutic Advances in Medical Oncology(2023)10.1177/17588359231210675

N/A

0.296DataRank · unranked

5 citations

Colt A. Egelston, Oscar Colunga Flores, Shyambabu Chaurasiya, David Pei‐Cheng Lin, Helen Chang +17 more

Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-0718

N/A

0.208DataRank · unranked

3 citations

Weihua Guo, Diana L. Simons, Jian Ye, Christian Avalos, Shawn T. Solomon +10 more

Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer

JCI Insight(2022)10.1172/jci.insight.153963

N/A

0DataRank · unranked

47 citations

Weihua Guo, Jiayi Tan, Christian Avalos, Diana L. Simons, Min Hui Lim +13 more

Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry Data

International Journal of Molecular Sciences(2021)10.3390/ijms22052316

N/A

0DataRank · unranked

19 citations

Grigoriy Gogoshin, Seth Hilliard, Lei Wang, Colt A. Egelston, Russell C. Rockne +3 more

A phase 1 trial of umbilical cord blood–derived tumor-reactive PD-L1+ natural killer cells engineered to express soluble IL-15 (TRACK-NK) in patients with non–small-cell lung cancer (NSCLC) refractory to PD-1/PD-L1 inhibitors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps2665

N/A

0DataRank · unranked

4 citations

Stephen J. Forman, Joycelynne Palmer, Timothy W. Synold, Lei Tian, Ting Lu +14 more

937 Comprehensive immune profiling unravels evolution of spatial distribution and immune repertoire in tumor microenvironment from primary to metastatic triple negative breast cancers

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0937

N/A

0DataRank · unranked

0 citations

Colt A. Egelston, Katherine E. Hutchinson, Jennifer M. Giltnane, Veronica Ibarra, Bonnie Liu +4 more

1012 Differentiation pathways of exhausted CD8+ T cells in human breast tumors

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.1012

N/A

0DataRank · unranked

0 citations

Jiayi Tan, Weihua Guo, Peter P. Lee, Colt A. Egelston

1035 CD26+ CD4+ T cells impart enhanced anti-tumor immunity and improved prognosis in early-stage breast cancer patients

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.1035

N/A

0DataRank · unranked

0 citations

Colt A. Egelston, Weihua Guo, Diana L. Simons, Christian Avalos, Peter P. Lee +1 more

Arhgap25 deficiency leads to decreased numbers of peripheral blood B cells and defective germinal center reactions

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.05.965228

N/A

0DataRank · unranked

0 citations

Colt A. Egelston, Stephanie M. Huard, Peter P. Lee, Leo D. Wang, Silke E. Lindner

Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy

Frontiers in Immunology(2024)10.3389/fimmu.2023.1274781

N/A

0DataRank · unranked

18 citations

Wilson S. Tang, Dongfang Wang, Damian Kaniowski, Elaine Kang, Nazlı Dizman +11 more

STING signalling compensates for low tumour mutation burden to drive anti-tumour immunity

EBioMedicine(2024)10.1016/j.ebiom.2024.105035

N/A

0DataRank · unranked

9 citations

Colt A. Egelston, Weihua Guo, Jeremy M. Stark, Peter P. Lee, Jiayi Tan

Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry Data

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.14.151100

N/A

0DataRank · unranked

4 citations

Grigoriy Gogoshin, Seth Hilliard, Lei Wang, Colt A. Egelston, Russell C. Rockne +3 more